Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting
Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus
Vancouver, BC / October 10-13, 2012
Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...
PRIORITY PRESS - 48th Annual Meeting of the European Association for the Study of Diabetes
Targeting the Kidney in the Treatment of Diabetes and Associated Cardiovascular Risk Factors
Berlin, Germany / October 1-5, 2012
Berlin - Barriers to effective type 2 diabetes mellitus treatment include risk of hypoglycemia and weight gain, which may be associated with an increased risk of mortality and cardiovascular (CV) events. The new class of selective sodium...
ABSTRACTS in PERSPECTIVE - Based on presentations from the 48th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Weighing Benefits of SGLT2 Inhibition in Type 2 Diabetes Mellitus
Berlin, Germany / October 1-5, 2012
EDITORIAL OVERVIEW: David C. W. Lau, MD, PhD, FRCPCEditor-in-Chief, Canadian Journal of DiabetesProfessor of Medicine, Biochemistry & Molecular BiologyJulia McFarlane Diabetes Research CentreUniversity of CalgaryCalgary, AlbertaRonald...
PRIORITY PRESS - 72nd Annual Scientific Sessions of the American Diabetes Association (ADA)
New Treatment Options in Type 2 Diabetes to Achieve Glycemic Goals and Prevent Complications
Philadelphia, Pennsylvania / June 8-12, 2012
Philadelphia - The prevalence of type 2 diabetes mellitus (T2DM) and its complications continues to grow. Outcomes in diabetes are still poor, primarily due to physical inactivity and failure to manage obesity. Failure to diagnose, treat...
PRIORITY PRESS - 22nd Scientific Meeting of the European Society of Hypertension
Optimizing Hypertension Treatment to Improve Renal Outcomes in Patients with Diabetes
London, UK / April 26-29, 2012
London - The first-line antihypertensive agent in patients with diabetes and either one additional cardiovascular (CV) risk factor, evidence of renal dysfunction, such as microalbuminuria, or both, is an ACE inhibitor or an angiotensin...
MEDICAL FRONTIERS - XVI International Symposium on Atherosclerosis
Cardiovascular Disease to Diabetes Prevention: The Potential of CETP Inhibition and Modulation
Sydney, Australia / March 25-29, 2012
Sydney - It is generally accepted that for every 0.1 mmol/L increase in HDL-C, there is an associated coronary artery disease risk reduction of ~10%. While raising HDL-C levels reduces the risk of atherosclerosis, a more specific focus on...
PRIORITY PRESS - 53rd Annual Meeting & Exposition of the American Society of Hematology
Simplifying Monitoring with Oral Anticoagulants
San Diego, California / December 10-13, 2011
San Diego - The choice of oral anticoagulants has expanded with the introduction of agents that do not require therapeutic drug monitoring. In new comparative data with warfarin, these agents are continuing to demonstrate advantages in a...
PRIORITY PRESS - American Heart Association (AHA) Scientific Sessions 2011
Differences Between Anticoagulants in Percutaneous Coronary Procedures
Orlando, Florida / November 12-16, 2011
Orlando - Anticoagulants and antiplatelets are considered essential for preventing recurrent thrombotic events in patients with an acute coronary syndrome or advanced cardiovascular (CV) disease. Once the standard, unfractionated heparin...
PRIORITY PRESS - American Heart Association (AHA) Scientific Sessions 2011
New Evidence that Glucose Control in Diabetes Offers Greater Protection Against CV Events and the CV Safety of Investigational Diabetes Agents
Orlando, Florida / November 12-16, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec There is evidence that better glucose control, measured over time by hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) or more acutely by blood...